Dow Jones

39 375,87

0,17%

DAX

Inscrivez-vous gratuitement pour obtenir des cotations en temps réel, des graphiques interactifs, un flux d'options en direct et plus encore.

S'inscrire

Accueil
Investir
Actions
Etats-Unis
NASDAQ
Trius Therapeutics, Inc. (MM) (TSRX)
Trius Therapeutics, Inc. (MM) (TSRX) Actualités

TSRX

Trius Therapeutics, Inc. (MM) (TSRX)

Trius Therapeutics, Inc. (MM)

De:

Actualités Réglementées

Mots clefs:

Trier par:

Actualités Non-réglementées

Showing the most relevant articles for your search:NASDAQ:TSRX

1 2 3 4 5 6 Suivant >>

Date	Heure	Source	Titre	Symbole	Société
14/02/2014	21h15	Edgar (US Regulatory)	Amended Statement of Ownership (sc 13g/a)	NASDAQ:TSRX	Trius Therapeutics, Inc. (MM)
10/10/2013	21h54	Edgar (US Regulatory)	Confidential Treatment Order (ct Order)	NASDAQ:TSRX	Trius Therapeutics, Inc. (MM)
23/09/2013	15h35	Edgar (US Regulatory)	Termination of Registration of a Class of Security Under Section 12(b) (15-12b)	NASDAQ:TSRX	Trius Therapeutics, Inc. (MM)
17/09/2013	12h00	Edgar (US Regulatory)	Notice of Effectiveness (effect)	NASDAQ:TSRX	Trius Therapeutics, Inc. (MM)
14/09/2013	00h25	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:TSRX	Trius Therapeutics, Inc. (MM)
13/09/2013	22h03	Edgar (US Regulatory)	Amended Statement of Beneficial Ownership (sc 13d/a)	NASDAQ:TSRX	Trius Therapeutics, Inc. (MM)
13/09/2013	22h03	Edgar (US Regulatory)	Post-effective Amendment to an S-8 Filing (s-8 Pos)	NASDAQ:TSRX	Trius Therapeutics, Inc. (MM)
13/09/2013	22h02	Edgar (US Regulatory)	Post-effective Amendment to Registration Statement (pos Am)	NASDAQ:TSRX	Trius Therapeutics, Inc. (MM)
11/09/2013	23h11	Edgar (US Regulatory)	Amended Statement of Ownership: Solicitation (sc 14d9/a)	NASDAQ:TSRX	Trius Therapeutics, Inc. (MM)
11/09/2013	23h10	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:TSRX	Trius Therapeutics, Inc. (MM)
11/09/2013	23h08	Edgar (US Regulatory)	Amended Tender Offer Statement by Third Party (sc To-t/a)	NASDAQ:TSRX	Trius Therapeutics, Inc. (MM)
11/09/2013	22h30	Business Wire	Cubist Pharmaceuticals Completes Acquisition of Trius Therapeutics	NASDAQ:TSRX	Trius Therapeutics, Inc. (MM)
11/09/2013	22h26	Edgar (US Regulatory)	(25-NSE)	NASDAQ:TSRX	Trius Therapeutics, Inc. (MM)
11/09/2013	17h00	Business Wire	Cubist Pharmaceuticals Announces Results of Tender Offer for Outstanding Shares of Trius Therapeutics	NASDAQ:TSRX	Trius Therapeutics, Inc. (MM)
06/09/2013	22h01	GlobeNewswire Inc.	Trius Therapeutics to Present Data From Antibiotics Development Programs at ICAAC 2013	NASDAQ:TSRX	Trius Therapeutics, Inc. (MM)
29/08/2013	22h00	Business Wire	Cubist Announces Expiration of Hart-Scott-Rodino Waiting Period for Acquisition of Trius	NASDAQ:TSRX	Trius Therapeutics, Inc. (MM)
13/08/2013	16h18	Edgar (US Regulatory)	Statement of Ownership: Solicitation (sc 14d9)	NASDAQ:TSRX	Trius Therapeutics, Inc. (MM)
13/08/2013	16h08	Edgar (US Regulatory)	Tender Offer Statement by Third Party (sc To-t)	NASDAQ:TSRX	Trius Therapeutics, Inc. (MM)
07/08/2013	22h47	Edgar (US Regulatory)	Quarterly Report (10-q)	NASDAQ:TSRX	Trius Therapeutics, Inc. (MM)
06/08/2013	22h00	GlobeNewswire Inc.	Trius Therapeutics Reports Second Quarter 2013 Financial Results	NASDAQ:TSRX	Trius Therapeutics, Inc. (MM)
06/08/2013	18h44	PR Newswire (US)	SHAREHOLDER ALERT: Law Office of Brodsky & Smith, LLC Announces Investigation of Trius Therapeutics, Inc. - TSRX	NASDAQ:TSRX	Trius Therapeutics, Inc. (MM)
05/08/2013	14h00	PR Newswire (US)	Strategic Initiatives, Executive Transitions, and Strengthened Portfolios to Increase Shareholder Value - Research Report on ...	NASDAQ:TSRX	Trius Therapeutics, Inc. (MM)
02/08/2013	17h14	Edgar (US Regulatory)	Written Communication Relating to an Issuer or Third Party (sc To-c)	NASDAQ:TSRX	Trius Therapeutics, Inc. (MM)
01/08/2013	21h12	Business Wire	Investigations into Proposed Buyouts of Optimer Pharmaceuticals, Inc., Trius Therapeutics, Inc. & Maidenform Brands, Inc. Ann...	NASDAQ:TSRX	Trius Therapeutics, Inc. (MM)
01/08/2013	17h20	Business Wire	TRIUS THERAPEUTICS SHAREHOLDER ALERT: Levi & Korsinsky Investigates Possible Breaches of Fiduciary Duty by Board of Trius The...	NASDAQ:TSRX	Trius Therapeutics, Inc. (MM)
01/08/2013	16h53	PR Newswire (US)	Ryan & Maniskas, LLP Announces Investigation of Trius Therapeutics, Inc.	NASDAQ:TSRX	Trius Therapeutics, Inc. (MM)
01/08/2013	14h00	Business Wire	Faruqi & Faruqi, LLP, Partner Juan E. Monteverde Launches an Investigation of Trius Therapeutics, Inc. Over the Proposed Sale...	NASDAQ:TSRX	Trius Therapeutics, Inc. (MM)
01/08/2013	03h54	Business Wire	TRIUS THERAPEUTICS INVESTOR ALERT BY THE FORMER ATTORNEY GENERAL OF LOUISIANA: Kahn Swick & Foti, LLC Investigates Trius Ther...	NASDAQ:TSRX	Trius Therapeutics, Inc. (MM)
31/07/2013	21h16	PR Newswire (US)	SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Trius Therapeutics, Inc. - TSRX	NASDAQ:TSRX	Trius Therapeutics, Inc. (MM)
31/07/2013	19h48	Business Wire	Rigrodsky & Long, P.A. Announces Investigation Of Trius Therapeutics, Inc. Buyout	NASDAQ:TSRX	Trius Therapeutics, Inc. (MM)